Alliance Enzyme Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 08-12-2024
- Paid Up Capital ₹ 1.71 M
as on 08-12-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.05 Cr
as on 08-12-2024
- Revenue %
(FY 2023)
- Profit 51.50%
(FY 2023)
- Ebitda -291.56%
(FY 2023)
- Net Worth -0.02%
(FY 2023)
- Total Assets -19.60%
(FY 2023)
About Alliance Enzyme
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.71 M.
The company currently has active open charges totaling ₹4.05 Cr.
Bharat Koradiya, Chandresh Vasani, and Sanjay Satasiya serve as directors at the Company.
- CIN/LLPIN
U24230GJ2012PTC069502
- Company No.
069502
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2012
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alliance Enzyme Private Limited offer?
Alliance Enzyme Private Limited offers a wide range of products and services, including Yarns & Threads, Yarn, Filament Yarn.
Who are the key members and board of directors at Alliance Enzyme?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Koradiya  | Director | 20-Mar-2012 | Current |
| Chandresh Vasani | Director | 20-Mar-2012 | Current |
| Sanjay Satasiya | Director | 20-Mar-2012 | Current |
Financial Performance of Alliance Enzyme.
Alliance Enzyme Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 51.5% increase in profit. The company's net worth dipped by a decrease of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alliance Enzyme?
In 2023, Alliance Enzyme had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 30 Jun 2012 | ₹3.00 Cr | Open |
Oriental Bank Of Commerce Creation Date: 30 Jun 2012 | ₹1.05 Cr | Open |
How Many Employees Work at Alliance Enzyme?
Alliance Enzyme has a workforce of 0 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alliance Enzyme, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alliance Enzyme's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
